# Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)

> **NCT04322669** · PHASE4 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 338 (actual)

## Conditions studied

- Recurrent Respiratory Tract Infections

## Interventions

- **DRUG:** Pidotimod
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04322669
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-04
- **Primary completion:** 2021-11-04
- **Final completion:** 2021-11-04
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322669, "Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04322669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*